AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-27.67%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$390M
AUM Growth
+$390M
(-49%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-50.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Denali Therapeutics
DNLI
$2.23B
| $102M | 26.13% |
3,668,749
| – | – |
|
|
KRTX
2
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $101M | 25.81% |
512,872
-800,000
| -61% | -$157M |
|
|
EQRX
3
DELISTED
EQRx, Inc. Common Stock
EQRX
| $89.4M | 22.89% |
36,335,375
| – | – |
|
4
Erasca
ERAS
$445M
| $47.6M | 12.2% |
11,055,554
| – | – |
|
|
VERV
5
DELISTED
Verve Therapeutics
VERV
| $38.9M | 9.96% |
2,008,809
| – | – |
|
|
OMIC
6
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $7.64M | 1.96% |
3,798,926
| – | – |
|
|
UBX
7
DELISTED
Unity Biotechnology
UBX
| $2.75M | 0.71% |
1,004,817
-9,043,364
| -90% | -$24.8M |
|
|
MTCR
8
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $1.32M | 0.34% |
2,940,503
| – | – |
|
|
RUBY
9
DELISTED
Rubius Therapeutics, Inc
RUBY
| – | – |
-349,908
| Closed | -$152K |
|
|
REVH
10
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| – | – |
-1,357,237
| Closed | -$13.3M |
|